Dr. Samir Suliman

Dr Samir Suliman graduated from medical school in 2005 and began his career training in surgery. During this time, he demonstrated a strong interest in innovation in healthcare by designing a remote patient monitoring software system that enabled doctors and patients to track progress and adjust management safely and efficiently.

Dr Suliman has extensive experience in medical weight management and has prescribed nearly 20,000 Ozempic pens. He is a strong advocate for the safe, evidence-based and clinically appropriate use of Semaglutide, including Wegovy, and is committed to ensuring patients are properly assessed, monitored and supported throughout their treatment journey.

He has witnessed first-hand the transformative impact that modern weight-loss medications can have when used responsibly within a structured medical framework. Dr Suliman recognises that obesity affects every aspect of a patient’s life — physically, mentally and practically — and that it can significantly impact both individuals and their families.

Dr Suliman’s approach focuses on safe prescribing, personalised care and long-term health improvement, helping patients reduce risk, improve quality of life and achieve sustainable outcomes under expert medical supervision.